Market Tracker

02/22 12:29pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.20
BATS BZX Real-Time Price
As of 12:27pm ET
 -0.10 / -0.40%
Today’s Change
16.40
Today|||52-Week Range
37.36
+34.04%
Year-to-Date

Today’s Trading

Previous close25.30
Today’s open25.40
Day’s range25.10 - 25.50
Volume13,557
Average volume (3 months)685,491
Market cap$1.2B
Dividend yield--
Data as of 12:27pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.24-0.71%
EGRXEagle Pharmaceutical...-0.23-0.31%
AXONAxovant Sciences Ltd+0.04+0.33%
ALDRAlder Biopharmaceuti...-0.45-2.00%
Data as of 12:27pm ET, 02/22/2017

Financials

Last reporting dateFebruary 14, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts